IGLON5 and movement disorder: A recent review has shown that apart from sleep disorders the most frequent neurological symptoms in anti‐IgLON5 disease include bulbar dysfunction, gait abnormalities, movement disorders, autonomic dysfunction, and neurocognitive alterations in different combinations and severity, leading to distinct clinical phenotypes.4